<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gitomer SA</submitter><funding>2020 Culshaw Young Investigator Award from the Children&amp;apos;s Hospital Colorado Center for Children&amp;apos;s Surgery</funding><funding>Colorado Clinical and Translational Sciences Institute</funding><pagination>e0277882</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9681069</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(11)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Little is known about olfactory changes in pediatric COVID-19. It is possible that children under-report chemosensory changes on questionnaires, similar to reports in adults. Here, we aim to describe COVID-19-related olfactory dysfunction in outpatient children. We hypothesized that children with COVID-19 will demonstrate abnormal olfaction on smell-identification testing at a higher rate than children with negative COVID-19 testing.&lt;h4>Methods&lt;/h4>A prospective cross-sectional study was undertaken from June 2020-June 2021 at a tertiary care pediatric hospital. A consecutive sample of 205 outpatients aged 5-21 years undergoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) PCR testing were approached for this study. Patients with prior olfactory dysfunction were excluded. Participants were given a standard COVID-19 symptom questionnaire, a Smell Identification Test (SIT) and home-odorant-based testing within 2 weeks of COVID-19 testing. Prior to study enrollment, power calculation estimated 42 patients to determine difference in rates of SIT results between groups. Data were summarized with descriptive statistics.&lt;h4>Results&lt;/h4>Fifty-one patients underwent smell identification testing (23 positive (45%) and 28 negative (55%) for COVID-19; mean age 12.7 years; 60% female). 92% of all patients denied subjective change in their sense of smell or taste but only 58.8% were normosmic on testing. There was no difference in screening questionnaires or SIT scores between COVID-19 positive and negative groups.&lt;h4>Conclusions&lt;/h4>Unlike adults, there was no statistical difference in olfactory function between outpatient COVID-19 positive and negative children. Our findings suggest a discrepancy between objective and patient-reported olfactory function in pediatric patients, and poor performance of current screening protocols at detecting pediatric COVID-19.</pubmed_abstract><journal>PloS one</journal><pubmed_title>Olfactory testing as COVID-19 screening in school children; A prospective cross-sectional study.</pubmed_title><pmcid>PMC9681069</pmcid><funding_grant_id>2380157</funding_grant_id><funding_grant_id>UL1 RR025780</funding_grant_id><pubmed_authors>Tholen K</pubmed_authors><pubmed_authors>Mistry RD</pubmed_authors><pubmed_authors>Beswick DM</pubmed_authors><pubmed_authors>Pickett K</pubmed_authors><pubmed_authors>Herrmann BW</pubmed_authors><pubmed_authors>Gitomer SA</pubmed_authors><pubmed_authors>Kaar JL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Olfactory testing as COVID-19 screening in school children; A prospective cross-sectional study.</name><description>&lt;h4>Background&lt;/h4>Little is known about olfactory changes in pediatric COVID-19. It is possible that children under-report chemosensory changes on questionnaires, similar to reports in adults. Here, we aim to describe COVID-19-related olfactory dysfunction in outpatient children. We hypothesized that children with COVID-19 will demonstrate abnormal olfaction on smell-identification testing at a higher rate than children with negative COVID-19 testing.&lt;h4>Methods&lt;/h4>A prospective cross-sectional study was undertaken from June 2020-June 2021 at a tertiary care pediatric hospital. A consecutive sample of 205 outpatients aged 5-21 years undergoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) PCR testing were approached for this study. Patients with prior olfactory dysfunction were excluded. Participants were given a standard COVID-19 symptom questionnaire, a Smell Identification Test (SIT) and home-odorant-based testing within 2 weeks of COVID-19 testing. Prior to study enrollment, power calculation estimated 42 patients to determine difference in rates of SIT results between groups. Data were summarized with descriptive statistics.&lt;h4>Results&lt;/h4>Fifty-one patients underwent smell identification testing (23 positive (45%) and 28 negative (55%) for COVID-19; mean age 12.7 years; 60% female). 92% of all patients denied subjective change in their sense of smell or taste but only 58.8% were normosmic on testing. There was no difference in screening questionnaires or SIT scores between COVID-19 positive and negative groups.&lt;h4>Conclusions&lt;/h4>Unlike adults, there was no statistical difference in olfactory function between outpatient COVID-19 positive and negative children. Our findings suggest a discrepancy between objective and patient-reported olfactory function in pediatric patients, and poor performance of current screening protocols at detecting pediatric COVID-19.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-05T14:41:22.911Z</modification><creation>2025-04-05T14:41:22.911Z</creation></dates><accession>S-EPMC9681069</accession><cross_references><pubmed>36413561</pubmed><doi>10.1371/journal.pone.0277882</doi></cross_references></HashMap>